Research

Gut microbiome and gastrointestinal dysfunction in people with autism

Vic Lin is a final-year PhD student in the Gut-Brain Axis Laboratory at RMIT University in Melbourne, Australia. His research focuses on understanding the gastrointestinal dysfunction commonly experienced by people with autism and exploring the connection between the gut microbiome and gastrointestinal function.

Immune mechanisms of coeliac disease and gluten-related disorders

Professor Jason Tye-Din is head of the Coeliac Research Laboratory at WEHI and a gastroenterologist at the Royal Melbourne Hospital. His expertise spans the immune mechanisms of coeliac disease, clinical care of gluten-related disorders, diagnostic discovery and pre-clinical and clinical drug development. His work aims to improve the health and quality of life of people suffering gastrointestinal immune diseases, particularly those caused by gluten and other foods.

Influence of gut microbes and inflammation on brain function and behaviour in autism

Third-year PhD candidate Angela Jimenez is part of the Gut-Brain Axis Laboratory at RMIT University in Melbourne, Australia. Angela holds a bachelor’s degree in neuroscience (Honours) from the National Autonomous University of Mexico (UNAM), and her doctoral research is currently supported by the RMIT–Mexico International Scholarship program.

Gerontological physiotherapy in falls prevention and prehabilitation

Dr Rik Dawson is a gerontological physiotherapist and health leader dedicated to improving healthy ageing through evidence-based physiotherapy, digital health and health system reform. As a Postdoctoral Researcher at the Institute for Musculoskeletal Health, University of Sydney, and President of the Australian Physiotherapy Association, he combines research and policy to improve access to high quality care for older people.

Applying artificial intelligence to medical imaging for cardiovascular disease detection

Parmida is a software engineer and biomedical scientist whose research focuses on translating novel medical imaging technologies into clinical practice to improve the diagnosis and management of cardiovascular disease.

Her current work applies advanced deep learning techniques to retinal polarization-sensitive optical coherence tomography (PS-OCT) imaging, aiming to generate clinically meaningful biomarkers and predictions of cardiovascular disease. Parmida’s collaboration partners include Fiona Stanley Hospital in Murdoch, Western Australia.

Medication management and quality use of medicines

Adjunct Professor Manya Angley is an Advanced Practice Pharmacist. Manya spent the first 20 years of her career as a teaching and research academic at the University of South Australia. She currently works as a credentialed pharmacist and researcher through her business, Manya Angley Research and Consulting (MARAC). 

Engineered proteins to repair or regrow damaged heart muscle cells and tissue

Associate Professor Dan Hesselson leads the Centre for Biomedical AI at the Centenary Institute.

He is an internationally trained research leader in regenerative medicine, focusing on cells and organs affected by heart disease, diabetes and cancer. His work uses insights from the study of basic regenerative processes to identify novel therapeutic targets for these devastating diseases.

Healthier Food Retail

Professor Anna Peeters AM is a globally recognised public health leader whose career has spanned academia, policy and health system reform, with a strong focus on prevention and health equity. She is the CEO of VicHealth, bringing decades of experience in epidemiology, population health and evidence-based health promotion.

Novel therapies & next-gen medical devices in cardiovascular & vascular disease management

Professor Shirley Jansen AM is a distinguished vascular and endovascular surgeon whose career spans clinical leadership, academic excellence, and pioneering research. She currently holds the Lawrence-Brown Chair of Vascular Surgery at Curtin University’s School of Population Health and serves as Head of the Department of Vascular Surgery at Sir Charles Gairdner Hospital, a role she has held since 2015. In addition, she is the Director of the Heart & Vascular Research Institute at the Harry Perkins Institute for Medical Research. Her early career was marked by prestigious fellowships, including a British Heart Foundation Research Fellowship (1996), and multiple international travelling fellowships from leading surgical societies and industry sponsors between 2001 and 2002.

Nuclear medicine & theranostics for molecular imaging & targeted therapy

Dr Aviral Singh is a globally renowned Nuclear Medicine Physician with special interest in Theranostics.

Dr Singh is based in Perth, Western Australia since 2024 and serves as the Clinical Head of Theranostics and Nuclear Medicine at GenesisCare Australia. He is also a Consultant Nuclear Medicine Physician at Fiona Stanley and Royal Perth Hospitals, in addition to pursuing national and international consulting physician roles as Director at Infinity Theranostics.

Scroll to top